Cargando…
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases
BACKGROUND: Interferon-β (IFN-β) is an effective drug in multiple sclerosis (MS) but it may cause acute exacerbation of MS following the initiation of treatment. This study evaluated patients with rapid exacerbation of multiple sclerosis (REMS) following the initiation of IFN-β. METHODS: We retrospe...
Autores principales: | Etemadifar, Masoud, Sarrami, Amir Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434905/ https://www.ncbi.nlm.nih.gov/pubmed/22973372 |
Ejemplares similares
-
Interleukin 18 Polymorphisms and its serum level in Patients with Multiple Sclerosis
por: Jahanbani-Ardakani, Hamidreza, et al.
Publicado: (2019) -
Fatigue, depression, and physical impairment in multiple sclerosis
por: Azimian, Mojtaba, et al.
Publicado: (2014) -
Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine
por: Etemadifar, Masoud, et al.
Publicado: (2023) -
Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies
por: Etemadifar, Masoud, et al.
Publicado: (2021) -
Evaluation of the prevalence of bovine leukemia virus DNA in peripheral blood mononuclear cells of multiple sclerosis patients
por: Jeda, Ali Salimi, et al.
Publicado: (2023)